Operating Lease, Right-of-Use Asset of Tourmaline Bio, Inc. from 01 Jan 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Tourmaline Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2022 to 30 Jun 2025.
Tourmaline Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $127,000, a 56% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Tourmaline Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$127,000	-$163,000	-56%	30 Jun 2025	10-Q	13 Aug 2025	2025	Q2
Q1 2025	$170,000	-$157,000	-48%	31 Mar 2025	10-Q	02 May 2025	2025	Q1
Q4 2024	$212,000	-$150,000	-41%	31 Dec 2024	10-Q	13 Aug 2025	2025	Q2
Q3 2024	$252,000	+$252,000		30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	$290,000	-$537,000	-65%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$327,000	-$725,000	-69%	31 Mar 2024	10-Q	13 May 2024	2024	Q1
Q4 2023	$362,000	-$127,000	-26%	31 Dec 2023	10-K	13 Mar 2025	2024	FY
Q3 2023	$0	-$2,842,000	-100%	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	$827,000	-$2,211,000	-73%	30 Jun 2023	10-Q	14 Aug 2023	2023	Q2
Q1 2023	$1,052,000	-$2,179,000	-67%	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$489,000	-$2,911,000	-86%	31 Dec 2022	10-K	19 Mar 2024	2023	FY
Q3 2022	$2,842,000			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$3,038,000			30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$3,231,000			31 Mar 2022	10-Q	12 May 2022	2022	Q1
Q4 2021	$3,400,000			01 Jan 2022	10-Q	14 Nov 2023	2023	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.